To be clear, I am still all in... My sentiment is still a buy. Just saying FDA future actions will likely be sluggish for some time.
- Forums
- ASX - By Stock
- MSB
- Cell Therapy News/Articles
MSB
mesoblast limited
Add to My Watchlist
1.92%
!
$1.79

Cell Therapy News/Articles, page-19653
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.79 |
Change
-0.035(1.92%) |
Mkt cap ! $2.306B |
Open | High | Low | Value | Volume |
$1.80 | $1.83 | $1.76 | $11.91M | 6.671M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 44994 | $1.79 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.80 | 28695 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1202 | 1.940 |
1 | 24 | 1.905 |
6 | 22155 | 1.885 |
3 | 21995 | 1.880 |
1 | 1614 | 1.845 |
Price($) | Vol. | No. |
---|---|---|
1.620 | 9592 | 3 |
1.685 | 24 | 2 |
1.690 | 2177 | 1 |
1.695 | 8147 | 1 |
1.705 | 45615 | 10 |
Last trade - 16.10pm 18/06/2025 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online